These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22348917)

  • 21. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A
    Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of diabetes and diabetes medications on bone health.
    Gilbert MP; Pratley RE
    Endocr Rev; 2015 Apr; 36(2):194-213. PubMed ID: 25738213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Knack of treatment with oral hypoglycemic drugs in the elderly].
    Komatsu M; Hashizume K
    Nihon Rinsho; 2006 Jan; 64(1):93-8. PubMed ID: 16408454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
    Mamza J; Mehta R; Donnelly R; Idris I
    Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management.
    Brown A; Desai M; Taneja D; Tannock LR
    Postgrad Med; 2010 Jan; 122(1):163-71. PubMed ID: 20107300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incretin-based therapy compared with non-insulin alternatives in elderly patients with type 2 diabetes.
    Zhao Q; Marcy TR
    Consult Pharm; 2013 Aug; 28(8):515-8. PubMed ID: 23906896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long term efficacy and tolerance of antidiabetic treatments. New data].
    Mirouze J
    Nouv Presse Med; 1974 Jun; 3(24):1551-4. PubMed ID: 4211493
    [No Abstract]   [Full Text] [Related]  

  • 28. Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult.
    Thompson AM; Linnebur SA; Vande Griend JP; Saseen JJ
    Consult Pharm; 2014 Feb; 29(2):110-23. PubMed ID: 24513421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors.
    Boland CL; Degeeter M; Nuzum DS; Tzefos M
    Ann Pharmacother; 2013 Apr; 47(4):490-505. PubMed ID: 23548652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological treatment of type 2 diabetes.
    Hermans MP; Buysschaert M
    Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
    [No Abstract]   [Full Text] [Related]  

  • 31. Managing type 2 diabetes: going beyond glycemic control.
    Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
    J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors.
    Kumar A
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():21-5. PubMed ID: 23280862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incretin therapies in the management of elderly patients with type 2 diabetes mellitus.
    Bourdel-Marchasson I; Schweizer A; Dejager S
    Hosp Pract (1995); 2011 Feb; 39(1):7-21. PubMed ID: 21441754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes mellitus: new drugs for a new epidemic.
    Nicholson G; Hall GM
    Br J Anaesth; 2011 Jul; 107(1):65-73. PubMed ID: 21610015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current therapies and emerging targets for the treatment of diabetes.
    Wagman AS; Nuss JM
    Curr Pharm Des; 2001 Apr; 7(6):417-50. PubMed ID: 11281851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel therapies in diabetes mellitus.
    Bandyopadhyay P
    Drug News Perspect; 2006 Oct; 19(8):499-507. PubMed ID: 17160152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contribution of diabetic research to versatile strategies for the treatment of diabetes mellitus].
    Niki I
    Nihon Yakurigaku Zasshi; 2003 Sep; 122(3):228-35. PubMed ID: 12939540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abstracts of the 21st Workshop of the Study Group on Artificial Insulin Delivery, Pancreas and Islet Transplantation (AIDPIT) of the European Association for the Study of Diabetes (EASD). Igls, Austria, January 27-29, 2002.
    Acta Diabetol; 2001 Dec; 38(4):193-216. PubMed ID: 12152599
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of non-insulin anti-diabetic agents to improve glycemia without hypoglycemia in the hospital setting: focus on incretins.
    Schwartz S; DeFronzo RA
    Curr Diab Rep; 2014 Mar; 14(3):466. PubMed ID: 24515252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Future therapeutic directions; new medications and insulin delivery in a changing world for effective diabetes management.
    Modi P
    Curr Drug Discov Technol; 2009 Sep; 6(3):200-13. PubMed ID: 19496750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.